Contango Announces 2025 Year End Financials and Provides 2026 and 2027 Production Guidance

Stock Information for RAPT Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About RAPT Therapeutics Inc.

Contango Stockholders Overwhelmingly Approve Merger with Dolly Varden
INDEPENDENT PROXY ADVISORY FIRMS RECOMMEND CONTANGO ORE, INC. STOCKHOLDERS VOTE "FOR" PROPOSED ARRANGEMENT WITH DOLLY VARDEN SILVER CORPORATION
Contango Ore Intersects 60.22 g/t Gold over 5.92 meters, including 294.77 g/t Gold over 1.16 meters from Underground Drilling Program at the Lucky Shot Project, Alaska, USA
CONTANGO ORE, INC. ANNOUNCES FILING AND MAILING OF SPECIAL MEETING PROXY STATEMENT IN CONNECTION WITH THE PROPOSED PLAN OF ARRANGEMENT WITH DOLLY VARDEN
Halper Sadeh LLC is Investigating Whether RAPT, CTGO, TBN, FOLD are Obtaining Fair Deals for their Shareholders
$HAREHOLDER ALERT: The M&A Class Action Firm Encourages $hareholders to Act Before the Vote-RAPT, FOLD, TBN, and CTGO
Contango Provides Corporate Update on Johnson Tract Critical Metals Project, Manh Choh Mine and Hedge Settlements
Are CTGO, FONR, CWAN Obtaining Fair Deals for their Shareholders?

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.